Measures | Baseline (0-week) (T0) | End of treatment (8-week) (T1) | The first follow-up (24-week) (T2) |
---|---|---|---|
Demographic characteristics | × | ||
PD history | × | ||
BBS | × | × | × |
TUG | × | × | × |
6WMT | × | × | × |
UPDRS-III | × | × | × |
PDQ-39 | × | × | × |
Adverse experiencesa | × | × | |
Combined medicationb | × | × |